source
- Novartis pays $125 million to acquire Sironax’s brain-delivery platformNovartis has exercised an option to buy Sironax’s platform for delivering large molecules across the blood‑brain barrier, with a $125 million payment due at closing. The technology is intended to…
- Yale and Harvard faculty question benefits of FDA's 'America First' user fee provisionsYale and Harvard medical school faculty have voiced concerns about the latest FDA user fee agreement, which includes a set of "America First" provisions. The provisions are designed to prioritize…